U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BROLUCIZUMAB-DBLL
FDA  
Preferred Name English
BEOVU
Brand Name English
Brolucizumab dbll [WHO-DD]
Common Name English
Code System Code Type Description
BIOLOGIC SUBSTANCE CLASSIFICATION CODE
XSZ53G39H5-DBLL-01
Created by admin on Wed Apr 02 03:36:39 GMT 2025 , Edited by admin on Wed Apr 02 03:36:39 GMT 2025
PRIMARY
SUBSTANCE RECORD
BROLUCIZUMAB-DBLL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966